Postoperative Rebound of Anti-Blood Type Antibodies and Antibody-Mediated Rejection After ABO-Incompatible Living Related Kidney Transplantation - Is Prophylactic Treatment Necessary?

被引：0
|
作者：
Ishida, H. [1 ]
Kondo, T. [1 ]
Shimizu, T. [1 ]
Nozaki, T. [1 ]
Tanabe, K. [1 ]
机构：
[1] Tokyo Womens Med Univ Hosp, Urol, Tokyo, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C1
引用
收藏
页码：601 / 601
页数：1
相关论文
共 50 条
  • [1] Postoperative rebound of anti-blood type antibodies and antibody-mediated rejection after ABO-incompatible living related kidney transplantation: Is prophylactic treatment necessary?
    Ishida, Hideki
    Shimizu, Tomokazu
    Omoto, Kazuya
    Okumi, Masayoshi
    Omoto, Kazunari
    [J]. TRANSPLANTATION, 2016, 100 (07) : S715 - S715
  • [2] POSTOPERATIVE REBOUND OF ANTI-BLOOD TYPE ANTIBODIES AND ANTIBODY-MEDIATED REJECTION AFTER ABO-INCOMPATIBLE LIVING RELATED KIDNEY TRANSPLANTATION. -IS PROPHYLACTIC TREATMENT NECESSARY?
    Hideki, Ishida
    Shimizu, Tomokazu
    Nozaki, Taiji
    Omoto, Kazuya
    Okumi, Masayoshi
    Tanabe, Kazunari
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 2 - 3
  • [3] Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation
    Ishida, Hideki
    Kondo, Tsunenori
    Shimizu, Tomokazu
    Nozaki, Taiji
    Tanabe, Kazunari
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 (03) : 286 - 296
  • [4] No Necessity for Prophylactic B-Cell-Targeting Treatment for Postoperative High Titers of Anti-Blood Type Antibodies After ABO-Incompatible Living Related Kidney Transplantation
    Ishida, H.
    Shimizu, T.
    Nozaki, T.
    Omoto, K.
    Inui, M.
    Shirakawa, H.
    Tanabe, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 514 - 514
  • [5] Daratumumab for treatment of antibody-mediated rejection after ABO-incompatible kidney transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    [J]. SWISS MEDICAL WEEKLY, 2019, : 14S - 15S
  • [6] Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    [J]. CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2019, 9 (03): : 149 - 157
  • [7] No Necessity for Prophylactic B-Cell-Targeting Treatment for Postoperative High Titers of Anti-Blood Type Antibodies After ABO-Incompatible Living Related Kidney Transplantation.
    Ishida, H.
    Shimizu, T.
    Nozaki, T.
    Omoto, K.
    Inui, M.
    Shirakawa, H.
    Tanabe, K.
    [J]. TRANSPLANTATION, 2014, 98 : 514 - 514
  • [8] Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation
    Maenosono, Ryoichi
    Unagami, Kohei
    Kakuta, Yoichi
    Furusawa, Miyuki
    Okumi, Masayoshi
    Azuma, Haruhito
    Ishida, Hideki
    Tanabe, Kazunari
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (12) : 1114 - 1120
  • [9] Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report
    Nishimura, Hiroaki
    Yamada, Yasutoshi
    Hisano, Satoshi
    Mitsuke, Akihiko
    Tatarano, Syuichi
    Gotanda, Takenari
    Hayami, Hiroshi
    Nakagawa, Masayuki
    Enokida, Hideki
    [J]. BMC NEPHROLOGY, 2018, 19
  • [10] Cryofiltration for removal of anti-blood group antibody in ABO-incompatible kidney transplantation
    Tanaka, M
    Tamaki, T
    Katori, M
    Takamine, Y
    Yokota, N
    Takahashi, M
    Osanai, M
    Naito, M
    Yasuhara, M
    Kukita, K
    Meguro, J
    Yonekawa, M
    Kawamura, A
    [J]. JAPANESE JOURNAL OF TRANSPLANTATION, 1998, 33 (02) : 116 - 122
12345